New drug halves death rate in those with severe COVID, maker claims

An experimental medication for critically ill COVID-19 patients appears to work so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization.
An experimental medication for critically ill COVID-19 patients appears to work so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization.